Medicines List

Description

Venlafaxine is an arylalkanolamine serotonin-norepinephrine reuptake inhibitor. It has a similar chemical structure to the opioid derivative tramadol, and has the tertiary amine functional group necessary for µ-opioid receptor recognition. It is surprisingly effective in treating depression in heroin and other opioid addicts compared to all other conventional antidepressants.

Indications

–  Treatment of major depressive episodes.

–  For prevention of relapse of new depressive episodes.

–  Treatment of generalized anxiety disorder.

–  Treatment of social anxiety disorder.

–  Treatment of panic disorder with or without agoraphobia.

Subject to medical prescription

Pharmaceutical form: 75 mg x 30 prolonged-release capsules

NHIF code: NF759

ICD: F31.3; F31.4; F31.5; F31.6; F31.7; F33.0; F33.1; F33.2; F33.3; F33.4

Pharmaceutical form: 150 mg x 30 prolonged-release capsules

NHIF code: NF760

ICD: F31.3, F31.4, F31.5, F31.6, F31.7, F33.0, F33.1, F33.2, F33.3, F33.4

Description

Co-Irbesso is a fixed-dose combination of an angiotensin-II receptor antagonist – irbesartan, and a thiazide diuretic – hydrochlorothiazide. The combination of these two ingredients has an additive antihypertensive effect which reduces blood pressure to a greater degree than either component alone.

Indications

Co-Irbesso is indicated:
– for treatment of essential hypertension;
– in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

Subject to medical prescription.

Concentrations and pharmaceutical form: 150 mg/12.5 mg, 300 mg/12.5 mg film-coated tablets

Patient information leaflet

Description

Felodipine is a calcium antagonist, a drug used to control hypertension (high blood pressure).

Indications

– Hypertension

– Stable angina

Subject to medical prescription

Pharmaceutical form: 5 mg x 30 prolonged-release tablets

NHIF code: CF 775

ICD: I10, I11.0, I11.9, I12.0, I12.9, I13.0, I13.1, I13.2, I20.1, I20.8, I20.9

Description

Buto-Asma is a pressurized suspension for inhalation and contains the active substance salbutamol as sulphate.
Salbutamol belongs to the group of bronchodilators (drugs that dilate the bronchi, facilitate breathing and soothe coughs).

Indications

Buto-Asma is used for:
– Symptomatic treatment of bronchospasm in patients with bronchial asthma and similar conditions associated with reversible airway obstruction;
– Prevention of bronchospasm induced by exercise or exposure to allergic attack.

Subject to medical prescription.

Concentration and pharmaceutical form: 0,1 mg/dose pressurised inhalation, suspension